Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Novacyt
  6. Company
    ALNOV   FR0010397232

NOVACYT

(ALNOV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novacyt
Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The Company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The Company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of distributors.
Sales per Business
2020
Primerdesign306.8998.4%
IT-IS International7.772.5%
Lab21 Products5.851.9%
EUR in Million
Sales per region
2020
United Kingdom246.7979.1%
Europe (Excluding United Kingdom)36.0311.6%
America11.603.7%
Asia-Pacific7.512.4%
Middle East6.462.1%
Africa3.431.1%
EUR in Million
Managers
Name Title Age Since
Graham David Mullis Chief Executive Officer & Executive Director 58 2014
James Martin Mccarthy Chief Financial Officer & Director 53 -
Reginald A. Trevor Chief Technology Officer - 2021
Lisa Henriet Director-Group Operations - 2016
Andrew John William Heath, Dr. Senior Independent Non-Executive Director 72 -
Edwin Snape, Dr. Independent Non-Executive Director 80 -
Juliet Thompson Independent Non-Executive Director 53 2017
Mandy Cowling Manager-Corporate & Investor Relations - 2012
Nick Plummer Secretary & General Counsel - 2021
Anthony Dyer Director & Chief Corporate Development Officer 48 2021
Members of the board
Name Title Age Since
James Christopher Wakefield Chairman 54 2014
Jean-Pierre Crinelli Non-Executive Director 70 2006
Graham David Mullis Chief Executive Officer & Executive Director 58 2014
Anthony Dyer Director & Chief Corporate Development Officer 48 2021
Andrew John William Heath, Dr. Senior Independent Non-Executive Director 72 -
Edwin Snape, Dr. Independent Non-Executive Director 80 -
Juliet Thompson Independent Non-Executive Director 53 2017
James Martin Mccarthy Chief Financial Officer & Director 53 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 70,626,248 70,040,918 99.2% 3,072 0.0% 99.2%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 1,986,434 2.81%
BlackRock Fund Advisors 760,994 1.08%
Octopus Investments Ltd. 627,421 0.89%
Ninety One UK Ltd. 294,675 0.42%
Argenta Banque d'Epargne SA 281,236 0.40%
Goldman Sachs Asset Management LP 122,073 0.17%
BlackRock Advisors (UK) Ltd. 120,563 0.17%
Andbank Wealth Management SGIIC SAU 109,999 0.16%
Schroder Investment Management Ltd. 98,593 0.14%
Lyxor International Asset Management SAS 96,465 0.14%
Holdings
NameEquities%Valuation
NOVACYT (ALNOV) 10,950 0.016% 49,462 USD
Markets and indexes
- PEA / SRD eligible : YES / NO
- Euronext Growth Paris
- Euronext Growth All-Share / CAC PME, EnterNext© PEA-PME 150, Next Biotech, OSEO Innovation, PEA, PEA-PME
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  ALNOV.PA
- Datastream Code :  
Company contact information
Novacyt
13 Avenue Morane Saulnier
FR-78140 Vélizy-Villacoublay

Phone : +33 (0)1 39 46 51 04
Fax : +33 (0)1 30 70 05 32
web site : http://www.novacyt.com
Sector Bio Medical Devices
1st jan.Capi. (M$)
NOVACYT-61.08%323
MICROPORT CARDIOFLOW MEDTECH CORPORATION0.00%3 794
MIMEDX GROUP, INC.33.26%1 329
SENSEONICS HOLDINGS, INC.249.85%1 305
COLLPLANT BIOTECHNOLOGIES LTD.62.77%174
ATTANA AB-27.45%35
Connections : Novacyt